Multivessel disease (MVD) affects approximately 50% of patients with acute coronary
syndromes (ACS) and is significantly burdened by poor outcomes and high mortality. It …

The prevalence of multivessel coronary artery disease (CAD) in acute coronary syndrome
(ACS) patients underscores the need for optimal revascularization strategies. The ongoing …

Background The presence of multivessel disease (MVD) is associated with poor outcomes
in patients with ACS. In patients with MVD without cardiogenic shock (CS), the optimal timing …

Multivessel coronary artery disease is a frequent finding in patients with acute myocardial
infarction. The proper management of nonculprit lesions in the setting of acute coronary …

A significant proportion of patients presenting with acute coronary syndromes (ACS) have
multivessel disease (MVD). Despite the abundance of clinical trials in this area, several …

Objectives The aim of this study was to evaluate the long-term outcomes of patients with
acute coronary syndromes (ACS) with multivessel disease undergoing percutaneous …

Background In patients with acute coronary syndrome and multivessel coronary disease,
complete revascularisation by percutaneous coronary intervention (PCI) is associated with …

Multivessel coronary artery disease is common in patients with acute coronary syndromes
(ACS), occurring in one-third to one-half of patients with either ST-segment elevation …

Background Whether revascularization should be performed as multivessel intervention at
the time of index procedure (MV‐index), staged procedure (MV‐staged), or culprit only …

Patients with acute coronary syndromes (ACS) and multivessel coronary artery disease are
frequently encountered during clinical practice and those patients are at higher risk of …